Stay updated on Avelumab Entinostat in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab Entinostat in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page footer revision version was incremented from v3.5.2 to v3.5.3, indicating a site release update rather than any modification to the clinical trial information.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision added: v3.5.2; revision v3.5.0 removed.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision history updated: added revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check87 days agoChange DetectedFallopian tube cancer was added to the conditions list, and the page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page now displays Revision: v3.4.1 instead of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avelumab Entinostat in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.